BioSpace News Archive

Biotech Beach

BIOLASE Announces Pricing of $8.5 Million Public Offering of Common Stock and Concurrent Private Placement of Convertible Preferred Stock

BIOLASE has granted the underwriters a 30-day over-allotment option to purchase up to an additional 1,173,000 shares of common stock at the public offering price, less the underwriting discount.

October 24, 2019
·
6 min read
Job Trends

PDL BioPharma Responds to Letter from Engine Capital

Harold E. Selick, Ph.D., Chairman of the Board of Directors of PDL BioPharma, has sent the following letter to Engine Capital, LP.

October 24, 2019
·
2 min read
Business

Amarin to Report Third Quarter 2019 Results and Host Conference Call on November 5, 2019

The conference call will follow the anticipated release of the company’s financial results earlier that day.

October 24, 2019
·
2 min read
Business

CRH Medical Corporation To Announce 2019 Third Quarter Results on November 7, 2019

The Company’s executive management will discuss the results during a conference call on Friday, November 8, 2019 at 9:00 am Eastern Time/6:00 am Pacific Time.

October 24, 2019
·
1 min read
Business

Brooks Automation Announces Fiscal 2019 Fourth Quarter and Year-End Earnings Conference Call and Webcast

The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, November 6, 2019 at 4:30 p.m.

October 24, 2019
·
1 min read
Business

/C O R R E C T I O N -- Menarini I.F.R./

His valuable experience will contribute towards bolstering the mission of the “Fondazione Internazionale Menarini” which welcomes the winner of the Nobel prize for Medicine, Louis Ignarro.

October 24, 2019
·
2 min read
CannTrust Provides Progress Update Regarding Remediation Plan

Special Committee investigation has concluded, Company continues to establish the foundation for a sustainable future

October 24, 2019
·
8 min read
Policy

Global Health Progress Launched to Drive Cross-sectoral Collaborations in Support of the Sustainable Development Goals (SDGs)

Global Health Progress is a new knowledge hub highlighting over 200 collaborations between the innovative biopharmaceutical industry and more than 850 partners to support the SDGs.

October 24, 2019
·
2 min read
Pharm Country

Progyny, Inc. Announces Pricing of Initial Public Offering

The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “PGNY” on October 25, 2019, and the offering is expected to close on October 29, 2019, subject to customary closing conditions.

October 24, 2019
·
2 min read
Business

Centers for Medicare and Medicaid Services Makes It Easier for Healthcare Providers to Choose Axolotl Biologix Products to Spur Wound and Tissue Regeneration

Axolotl’s DualGraft™ and Axolotl Graft™ products have been assigned the code Q4210.

October 24, 2019
·
1 min read